Galectin Therapeutics Inc.
Galectin Therapeutics Inc. scores highest on Torque (96) and lowest on Price (0). Its PosiPenta is 50.76 out of 100, around the middle of similar companies.
On the Penta Grid this week, Galectin Therapeutics Inc. is Grid #274 of 837 in the Healthcare sector in United States, and Grid #1,790 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc. | 50.76 | 0 | 33 | 54 | 96 | 71 |
| Scribe Therapeutics Inc. | 45.15 | 0 | 22 | 51 | 93 | 59 |
| Enanta Pharmaceuticals, Inc. | 35.04 | 21 | 26 | 54 | 25 | 50 |
| Zura Bio Limited | 52.38 | 30 | 47 | 47 | 68 | 69 |
| Relmada Therapeutics, Inc. | 50.03 | 32 | 56 | 42 | 67 | 54 |
| Nautilus Biotechnology, Inc. | 46.30 | 29 | 37 | 53 | 49 | 63 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -8.42 |
| P/B ratio | -2.67 |
EEarnings
| Trailing EPS | ₹-40.73 |
| Forward EPS | ₹-159.12 |
NNitro
| Price | 342.87 |
| 52-week high | 675.32 |
| 52-week low | 192.27 |
| Fall from 52-week high | 49.2% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.06 |
AAnchor
| Beta (price swings) | 0.38 |
| Market cap | ₹3,457 Cr |
| Insider holding | 52.80% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Galectin Therapeutics Inc.'s PosiPenta score?
Galectin Therapeutics Inc.'s PosiPenta is 50.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Galectin Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Galectin Therapeutics Inc. is Grid #274 of 837 in the Healthcare sector in United States, and Grid #1,790 of 4,000 in United States.
Which PosiPenta pillar is strongest for Galectin Therapeutics Inc.?
Torque (durability), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Galectin Therapeutics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Galectin Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 3.43 points, from 47.33 to 50.76.
PositoAI is for research and education only and is not investment advice.